- Home
- CBAT vs JSPR Comparison
CBAT vs JSPR Comparison
Compare CBAT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- JSPR
- Stock Information
- Founded
- CBAT 1999
- JSPR 2018
- Country
- CBAT China
- JSPR United States
- Employees
- CBAT N/A
- JSPR N/A
- Industry
- CBAT Industrial Machinery/Components
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CBAT Miscellaneous
- JSPR Health Care
- Exchange
- CBAT Nasdaq
- JSPR Nasdaq
- Market Cap
- CBAT 90.8M
- JSPR 85.8M
- IPO Year
- CBAT N/A
- JSPR N/A
- Fundamental
- Price
- CBAT $1.21
- JSPR $5.58
- Analyst Decision
- CBAT
- JSPR Strong Buy
- Analyst Count
- CBAT 0
- JSPR 11
- Target Price
- CBAT N/A
- JSPR $62.22
- AVG Volume (30 Days)
- CBAT 294.1K
- JSPR 229.8K
- Earning Date
- CBAT 08-08-2025
- JSPR 08-12-2025
- Dividend Yield
- CBAT N/A
- JSPR N/A
- EPS Growth
- CBAT N/A
- JSPR N/A
- EPS
- CBAT 0.00
- JSPR N/A
- Revenue
- CBAT $152,731,078.00
- JSPR N/A
- Revenue This Year
- CBAT $28.79
- JSPR N/A
- Revenue Next Year
- CBAT $36.77
- JSPR N/A
- P/E Ratio
- CBAT $13,555.56
- JSPR N/A
- Revenue Growth
- CBAT N/A
- JSPR N/A
- 52 Week Low
- CBAT $0.57
- JSPR $3.13
- 52 Week High
- CBAT $1.75
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- CBAT 76.57
- JSPR 55.28
- Support Level
- CBAT $0.83
- JSPR $5.40
- Resistance Level
- CBAT $1.24
- JSPR $6.13
- Average True Range (ATR)
- CBAT 0.07
- JSPR 0.44
- MACD
- CBAT 0.02
- JSPR -0.01
- Stochastic Oscillator
- CBAT 92.50
- JSPR 58.39
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.